Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label extension of lacosamide adjunctive therapy in pediatric epilepsy with partial-onset seizures
2012-005012-26Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in Focal Onset Epilepsy and epilepsy, sponsored by UCB. Primary endpoint: Number of subjects reporting at least one treatment-emergent adverse event. Started Oct 2013; status: completed.
02
Drugs
lacosamide
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on 2012-005012-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005012-26.